APA (7th ed.) Citation

Kaduthanam, S., Gade, S., Meister, M., Brase, J. C., Johannes, M., Dienemann, H., . . . Kuner, R. (2013). Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung cancer, 80(2), . https://doi.org/10.1016/j.lungcan.2013.01.013

Chicago Style (17th ed.) Citation

Kaduthanam, Sajo, et al. "Serum MiR-142-3p Is Associated with Early Relapse in Operable Lung Adenocarcinoma Patients." Lung Cancer 80, no. 2 (2013). https://doi.org/10.1016/j.lungcan.2013.01.013.

MLA (9th ed.) Citation

Kaduthanam, Sajo, et al. "Serum MiR-142-3p Is Associated with Early Relapse in Operable Lung Adenocarcinoma Patients." Lung Cancer, vol. 80, no. 2, 2013, https://doi.org/10.1016/j.lungcan.2013.01.013.